EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mechanism of Inhibition of the Active Triphosphate Form of 2′-α-Fluoro,2′-β-bromouridine against Yellow Fever Virus RNA-Dependent RNA Polymerase

Calvin Joel Gordon iD, Simon Maximus Walker, Julia Christine LeCher, Franck Amblard, Raymond Felix Schinazi iD, Matthias Götte iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Calvin Joel Gordon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada. Hauptthemen laut MEDLINE: RNA-Dependent RNA Polymerase, Antiviral Agents, Yellow fever virus, Uridine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Canadian Institutes of Health Research, Division of Microbiology and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Dependent RNA PolymeraseAntiviral AgentsYellow fever virusUridineAnimalsVirus ReplicationProdrugsHumansViral Nonstructural Proteins

Stichwörter der Autor:innen

RNA-dependent RNA polymeraseantiviralflavivirusnucleotide analogssofosbuviryellow fever virus

Substanzen

RNA-Dependent RNA PolymeraseAntiviral AgentsUridineProdrugsViral Nonstructural Proteins

Autor:innen und Institutionen

  • Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
  • Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia 30322, United States.

ORCID-Profile: Calvin Joel Gordon, Raymond Felix Schinazi, Matthias Götte

Förderung

  • NIAID NIH HHS
  • Canadian Institutes of Health Research
  • Division of Microbiology and Infectious Diseases
  • Ministry of Technology and Innovation, Government of Alberta

Zitieren

APA

Gordon, C. J., Walker, S. M., LeCher, J. C., Amblard, F., Schinazi, R. F., & Götte, M. (2025). Mechanism of Inhibition of the Active Triphosphate Form of 2′-α-Fluoro,2′-β-bromouridine against Yellow Fever Virus RNA-Dependent RNA Polymerase. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00086

Vancouver

Gordon CJ, Walker SM, LeCher JC, Amblard F, Schinazi RF, Götte M. Mechanism of Inhibition of the Active Triphosphate Form of 2′-α-Fluoro,2′-β-bromouridine against Yellow Fever Virus RNA-Dependent RNA Polymerase. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00086

BibTeX
@article{Gordon2025,
  author = {Gordon, Calvin Joel and Walker, Simon Maximus and LeCher, Julia Christine and Amblard, Franck and Schinazi, Raymond Felix and Götte, Matthias},
  title = {Mechanism of Inhibition of the Active Triphosphate Form of 2′-α-Fluoro,2′-β-bromouridine against Yellow Fever Virus RNA-Dependent RNA Polymerase},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00086}
}
Kostenlos starten →